Sanofi

FDA approves Sanofi’s long-lasting hemophilia drug
BioPharma Dive
Thu, 02/23/23 - 04:32 pm
Sanofi
FDA
hemophilia A
Altuviiio
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Fierce Pharma
Tue, 02/21/23 - 10:26 am
Pfizer
RSV
vaccines
GSK
AstraZeneca
Sanofi
RSVpreF
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
RSV
vaccines
GSK
Pfizer
Sanofi
Sobi
Moderna Therapeutics
AstraZeneca
JNJ
FDA
Sanofi and Regeneron face a high-risk test for Dupixent
EP Vantage
Fri, 02/17/23 - 10:20 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Pfizer
Viatris
Sanofi
Regeneron
patents
Supreme Court
Reed relinquishes R&D reins at Sanofi to pursue new opportunity, sparking race to find successor
Fierce Biotech
Mon, 02/13/23 - 10:36 am
R&D
Sanofi
John Reed
Dupixent kicks off 2023 as top pharma brand for ad impressions
Medical Devices and Diagnostics Industry
Mon, 02/6/23 - 06:13 pm
Sanofi
Dupixent
asthma
pharma advertising
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Fierce Pharma
Mon, 02/6/23 - 10:58 am
Sanofi
Dupixent
earnings
Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
BioSpace
Fri, 02/3/23 - 10:31 am
Sanofi
tolebrutinib
myasthenia gravis
New competitors push Sanofi to offer voluntary retirement packages at two Indian sites
Endpoints
Tue, 01/31/23 - 11:20 pm
Sanofi
India
drug manufacturing
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
AstraZeneca
Sanofi
Novo Nordisk
340B
drug discounts
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Sanofi dives deeper into phase 3 data for Hemlibra rival as FDA decision approaches
Fierce Biotech
Thu, 01/26/23 - 10:47 am
Sanofi
FDA
clinical trials
hemophilia A
efanesoctocog alfa
Roche
Hemlibra
Sanofi takes to TikTok and Instagram to target millennials and older Gen Z parents for RSV education
Endpoints
Wed, 01/25/23 - 10:51 pm
Sanofi
social media
TikTok
Instagram
RSV
pharma marketing
Sanofi promises money back for discontinued blood disorder treatment – in some cases
Endpoints
Mon, 01/23/23 - 10:00 pm
Sanofi
drug warranty programs
Cablivi
aTTP
Sanofi and CytoReason target IBD in expanded collaboration
Pharma Live
Mon, 01/23/23 - 11:03 am
Sanofi
CytoReason
IBD
R&D
JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor
BioPharma Dive
Wed, 01/11/23 - 11:08 pm
JPMHC 2023
Takeda
Bristol Myers Squibb
Prime Medicine
Sanofi
Sanofi extends commitment to $750M biotech startup fund
Endpoints
Wed, 01/11/23 - 10:55 pm
Sanofi
Sanofi Ventures
funding
JPM23: Sanofi has reached the 'steady state' Paul Hudson envisioned years ago, CEO says
Fierce Pharma
Wed, 01/11/23 - 10:54 am
JPMHC 2023
Sanofi
Paul Hudson
Pharma CEOs
Dupixent
JPM Day 2: Highlights
BioSpace
Tue, 01/10/23 - 06:50 pm
JPMHC 2023
Relay Therapeutics
Sanofi
Scholar Rock
SAGE Therapeutics
Karuna Therapeutics
GSK

Pages